Tonomoto et al. studied 61 ESCC clinical samples and found that methylation of the RUNX3 promoter region resulted in the absence of RUNX3 expression in tumor tissues [87]. The gene discussed is RUNX3; the disease is esophageal squamous cell carcinoma.